Stay updated on Eteplirsen Safety in Early Duchenne Clinical Trial
Sign up to get notified when there's something new on the Eteplirsen Safety in Early Duchenne Clinical Trial page.

Latest updates to the Eteplirsen Safety in Early Duchenne Clinical Trial page
- Check3 days agoChange DetectedRevision updated to v3.0.2 (replacing v3.0.1) and the Back to Top element was removed; no other substantive changes were observed.SummaryDifference0.2%
- Check10 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.SummaryDifference0.2%
- Check17 days agoChange DetectedThe web page has updated its facility name and location details, specifically adding 'St Louis, Missouri, United States, 63110' and 'eteplirsen' while removing previous mentions of related muscular dystrophy topics.SummaryDifference2%
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
- Check38 days agoChange DetectedThe web page has been updated from version v2.16.10 to v2.16.11.SummaryDifference0.1%
- Check45 days agoChange DetectedThe web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.SummaryDifference1%
Stay in the know with updates to Eteplirsen Safety in Early Duchenne Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Eteplirsen Safety in Early Duchenne Clinical Trial page.